Radotinib
Product Specifications
CAS Number
926037-48-1
Target
Apoptosis, STAT, JAK, Bcr-Abl
Related Pathways
Stem Cells, Angiogenesis, JAK/STAT signaling, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Chromatin/Epigenetic, Apoptosis
Purity
0.9997
Bioactivity
Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
Smiles
Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cnccn3)c2)cc(c1)C(F)(F)F
Molecular Formula
C27H21F3N8O
Molecular Weight
530.5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
